In a call with analysts Tuesday, the same day the Centers for Disease Control Prevention signed off on Emergency Use Authorization of Pfizer’s COVID vaccine for 5- to 11-year-olds, Pfizer boosted its 2021 sales forecast from $33.5 billion to $36 billion.
https://childrenshealthdefense.org/defender/pfizer-covid-vaccine-sales-billions/?
